HAS3 and chronic obstructive pulmonary disease: Excluding these samples, i.e. a below limit detection of HAS-3 expression, revealed enhanced expression in patients with COPD compared to smoking controls (Fig. S1, online supplement), yet, no longer when adjusting for age- and sex (p = 0.231).